Last reviewed · How we verify

NCT04107662

Biomarkers of Traumatic Brain Injury With Tbit System

Not yet recruiting Last updated 5 April 2024
What this trial tests

trial testing Tbit system in Brain Injuries, Traumatic in 740 participants. Not yet recruiting.

Timeline
1 December 2024
Primary endpoint
30 May 2025
30 May 2025

Quick facts

Lead sponsorBioDirection Inc
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment740
Start date1 December 2024
Primary completion30 May 2025
Estimated completion30 May 2025

Drugs / interventions tested

Conditions studied

Sponsor

BioDirection Inc

Who can join

18 and older, any sex, with Brain Injuries, Traumatic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective, multi-center, non-randomized, pivotal study to assess the safety and efficacy of the Tbit™ System to aid in patient evaluation, suspected of traumatic brain injury, as adjunct companion test to radiologic standard of care, Cranial Computerized Tomography (CCT).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Brain Injuries, Traumatic

Currently open trials in the same condition.

Other BioDirection Inc trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04107662.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing